Highlights and Quick Summary
- EPS Growth (basic) for the quarter ending March 31, 2023 was 60.0% (a -39.9% decrease compared to previous quarter)
- Year-over-year quarterly EPS Growth (basic) decreased by -39.38%
- Annual EPS Growth (basic) for 2022 was 0.0% (a -100.0% decrease from previous year)
- Annual EPS Growth (basic) for 2022 was 99.65% (a -100.5% decrease from previous year)
- Annual EPS Growth (basic) for 2021 was -19900.0% (a -33200.47% decrease from previous year)
- Twelve month EPS Growth (basic) ending March 31, 2023 was 99.19% (a -0.32% decrease compared to previous quarter)
- Twelve month trailing EPS Growth (basic) increased by 45.04% year-over-year
Trailing EPS Growth (basic) for the last four month:
| 31 Mar '23 | 31 Dec '22 | 30 Sep '22 | 30 Jun '22 |
|---|---|---|---|
| 99.19% | 99.51% | 68.27% | 68.39% |
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EPS Growth (basic) of Benitec Biopharma Limited
Most recent EPS Growth (basic)of BNTC including historical data for past 10 years.Interactive Chart of EPS Growth (basic) of Benitec Biopharma Limited
Benitec Biopharma Limited EPS Growth (basic) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 60.0% | – | – | – | – |
| 2022 | 99.83% | 24.19% | 98.97% | 99.76% | 0.0% |
| 2021 | 22.0% | 74.69% | -2961.22% | -8134.5% | -19900.0% |
| 2020 | – | -11188.06% | 25.75% | -263.35% | 0.0% |
| 2019 | – | – | -143.9% | -76.32% | 13.11% |
| 2018 | – | – | – | – | 0.32% |
| 2017 | – | – | – | -34.69% | -36648.0% |
| 2016 | 161.22% | – | – | – | -29206.15% |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology